Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Sai Murali Krishna Pulukuri, Hugues Bernard et al.|Nature Chemical Biology|2017Cited by 228
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven Langston, Xiaofeng Yang, Scott Freeze et al.|Journal of Medicinal Chemistry|2021Cited by 205
Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous RouteŠtěpán Vyskočil, Ji Zhang, Nina Molchanova et al.|Journal of Medicinal Chemistry|2021Cited by 42